课题基金 / 基金详情

General Clinical Research Center

General Clinical Research Center
全科临床研究中心
批准号:
7591148
负责人:
ERIK L HEWLETT
金额:
$478.77万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-05-01 至 2011-02-28

项目摘要

项目成果

ERIK L HEWLETT的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
EXCEED THE SPACE PROVIDED. Clinical investigation at the UVA GCRC is in its 31st year, and we request support for years 33-37. Our GCRC has longstanding strengths in neuroendocrinology, allergy, reproductive medicine, immunotherapy of cancer, and diabetes. These persist. In the past 2 years we have attracted a new cadre of GCRC investigators from Cardiology, vascular biology, and from the Center for Alternative Medicine program in the School of Nursing. With the recent recruitment of new research intensive leadership in our divisions of Cardiovascular Medicine, Hematology and Oncology, and our Department of Psychiatry and Behavioral Medicine, we anticipate continued growth and vitality of our research programs. In the past 2 years, we have also had major upgrades in our core assay program thereby facilitating sample throughput to >100,000/yr while freeing personnel time to implement additional analytical services. We have initiated a new GCRC imaging laboratory to allow studies of endothelial dysfunction in setting of diabetes, insulin resistance, and PCOS and microvascular perfusion in multiple organs including heart, muscle and kidney. The UVA GCRC has enjoyed an excellent record of productivity (>170 publications over the past 4 yrs). Its exercise, informatics and biomathematics cores have been national leaders in their innovative support for clinicalinvestigations. The GCRC enjoys a stable core of NIH-funded established investigators and is developing through our educational and mentoring programs another generation of skilled clinical investigators. We are particularly proud of our CAP and K award winners. During the last 3 years, we have seen (as has been a national trend) a growth in outpatient studies while inpatient studies, particularly those that have involved 24 hr blood sampling, have decreased. We have pro- actively begun working with the UVA Health System to plan a redesigned GCRC with expanded space and greater accessibility for outpatients that would accommodate current and projected usage.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
11th International Symposium on Bordetella
  • 批准号:
    9053803
  • 项目类别:
  • 资助金额:
    $0.5万
  • 财政年份:
    2016
  • 负责人:
    ERIK L HEWLETT
  • 依托单位:
Integrated analysis of cellular responses to toxins from clostridium difficile
  • 批准号:
    8233381
  • 项目类别:
  • 资助金额:
    $32.89万
  • 财政年份:
    2011
  • 负责人:
    ERIK L HEWLETT
  • 依托单位:
Bordetella cyclase toxin: effects on leukocytes and respiratory epithelial cells
  • 批准号:
    7846692
  • 项目类别:
  • 资助金额:
    $3.22万
  • 财政年份:
    2009
  • 负责人:
    ERIK L HEWLETT
  • 依托单位:
Integrated analysis of cellular responses to toxins from clostridium difficile
  • 批准号:
    7670083
  • 项目类别:
  • 资助金额:
    $32.26万
  • 财政年份:
    2009
  • 负责人:
    ERIK L HEWLETT
  • 依托单位:
国内基金
海外基金
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data